Inhibition of Sterile Inflammation by Digoxin

  • End date
    Jul 28, 2023
  • participants needed
  • sponsor
    Yale University
Updated on 25 June 2021


To investigate the effect of digoxin on pyruvate kinase isoform 2 (PKM2) binding to pro-inflammatory loci and innate immune inflammatory responses in the peripheral blood in healthy subjects.


To investigate the effect of orally administered digoxin on innate immune inflammatory responses in the peripheral blood of healthy subjects. We hypothesize the reduction in innate immune inflammatory responses will be expected in the peripheral blood with the effect of oral digoxin.

To investigation of how human peripheral blood immune cells change their inflammatory responses after exposure to digoxin in vitro.

Condition Inflammatory Response, inflammatory responses
Treatment Placebo, Digoxin
Clinical Study IdentifierNCT03559868
SponsorYale University
Last Modified on25 June 2021


Yes No Not Sure

Inclusion Criteria

Age >18 y 70 years
subjects with normal serum creatinine, normal EKG and currently not taking any medication

Exclusion Criteria

Autoimmune liver disease (ANA > 1/320)
Chronic viral hepatitis
Hepatocellular carcinoma
Complete portal vein thrombosis
Extrahepatic terminal disease
Treatment with prednisolone or pentoxifyllin for more than 3 days prior to inclusion/start date
Active alcohol abuse (>50 g/day for men and >40 g/day for women) in the last 3 months
AST > ALT and total bilirubin > 3 mg/dl in the past 3 months
Liver biopsy and/or clinical picture consistent with alcoholic hepatitis
Lack of signed informed consent
Known hypersensitivity to digoxin or other forms of digitalis, ventricular fibrillation
Any significant medical conditions, any electrolyte abnormalities, over the counter medications, natural products and prescription drugs
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note